 Diana Cittelly
Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 9 | 2025 | 1171 | 2.150 |
Why?
| | Breast Neoplasms | 16 | 2025 | 2142 | 1.940 |
Why?
| | MicroRNAs | 9 | 2018 | 678 | 1.270 |
Why?
| | Triple Negative Breast Neoplasms | 4 | 2019 | 197 | 1.130 |
Why?
| | Estradiol | 3 | 2019 | 494 | 0.860 |
Why?
| | Brain Edema | 1 | 2023 | 60 | 0.840 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 5 | 0.760 |
Why?
| | Receptor, trkB | 2 | 2019 | 30 | 0.720 |
Why?
| | Tamoxifen | 4 | 2016 | 200 | 0.710 |
Why?
| | Astrocytes | 2 | 2023 | 201 | 0.620 |
Why?
| | Estrogens | 4 | 2023 | 347 | 0.610 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2019 | 114 | 0.590 |
Why?
| | Gene Expression Regulation, Neoplastic | 11 | 2025 | 1356 | 0.570 |
Why?
| | bcl-X Protein | 3 | 2007 | 42 | 0.570 |
Why?
| | Heterografts | 2 | 2019 | 131 | 0.550 |
Why?
| | Cell Line, Tumor | 14 | 2025 | 3215 | 0.550 |
Why?
| | Progesterone | 3 | 2014 | 245 | 0.500 |
Why?
| | Progestins | 2 | 2014 | 78 | 0.490 |
Why?
| | Spinal Cord Injuries | 3 | 2007 | 194 | 0.480 |
Why?
| | Paracrine Communication | 1 | 2015 | 61 | 0.480 |
Why?
| | Endothelial Cells | 1 | 2020 | 749 | 0.450 |
Why?
| | Xenograft Model Antitumor Assays | 6 | 2025 | 814 | 0.390 |
Why?
| | Antineoplastic Agents, Hormonal | 3 | 2016 | 158 | 0.380 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2012 | 67 | 0.380 |
Why?
| | Ovarian Neoplasms | 2 | 2019 | 490 | 0.380 |
Why?
| | Paclitaxel | 1 | 2012 | 217 | 0.370 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2019 | 759 | 0.360 |
Why?
| | Hyaluronan Receptors | 3 | 2025 | 96 | 0.360 |
Why?
| | Receptor, ErbB-2 | 3 | 2019 | 326 | 0.350 |
Why?
| | Aquaporin 4 | 2 | 2023 | 95 | 0.350 |
Why?
| | Genes, bcl-2 | 1 | 2010 | 21 | 0.350 |
Why?
| | Estrogen Antagonists | 1 | 2010 | 45 | 0.350 |
Why?
| | Mammary Glands, Animal | 1 | 2010 | 124 | 0.320 |
Why?
| | Mice | 14 | 2025 | 16937 | 0.320 |
Why?
| | Helicobacter pylori | 3 | 2005 | 37 | 0.300 |
Why?
| | Radiosurgery | 2 | 2023 | 321 | 0.290 |
Why?
| | Apoptosis | 6 | 2020 | 2503 | 0.280 |
Why?
| | Cell Proliferation | 4 | 2021 | 2391 | 0.280 |
Why?
| | Cell Movement | 4 | 2025 | 945 | 0.270 |
Why?
| | Animals | 18 | 2025 | 35361 | 0.260 |
Why?
| | Stem Cells | 1 | 2010 | 577 | 0.250 |
Why?
| | Neoplasm Metastasis | 2 | 2020 | 610 | 0.250 |
Why?
| | Immunohistochemistry | 5 | 2016 | 1698 | 0.250 |
Why?
| | Mucin 5AC | 1 | 2025 | 69 | 0.230 |
Why?
| | Cell Differentiation | 1 | 2012 | 1902 | 0.230 |
Why?
| | Transduction, Genetic | 2 | 2016 | 128 | 0.230 |
Why?
| | Stomach Neoplasms | 2 | 2002 | 99 | 0.220 |
Why?
| | Gastritis | 2 | 2002 | 96 | 0.220 |
Why?
| | Mice, Nude | 3 | 2020 | 683 | 0.220 |
Why?
| | Female | 23 | 2025 | 68776 | 0.220 |
Why?
| | Ribonuclease III | 2 | 2016 | 37 | 0.210 |
Why?
| | Tumor Microenvironment | 4 | 2020 | 634 | 0.210 |
Why?
| | Receptors, Estrogen | 2 | 2016 | 426 | 0.210 |
Why?
| | DEAD-box RNA Helicases | 2 | 2016 | 66 | 0.210 |
Why?
| | Humans | 28 | 2025 | 129650 | 0.210 |
Why?
| | Edema | 1 | 2023 | 124 | 0.200 |
Why?
| | Anoikis | 2 | 2012 | 31 | 0.200 |
Why?
| | Hydrocephalus | 1 | 2023 | 107 | 0.190 |
Why?
| | Peptic Ulcer | 1 | 2002 | 18 | 0.190 |
Why?
| | Mice, SCID | 2 | 2012 | 351 | 0.190 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1181 | 0.190 |
Why?
| | Neoplasm Invasiveness | 3 | 2020 | 485 | 0.180 |
Why?
| | Estrogen Receptor alpha | 2 | 2014 | 133 | 0.180 |
Why?
| | 3' Untranslated Regions | 2 | 2012 | 138 | 0.180 |
Why?
| | DNA, Bacterial | 1 | 2002 | 324 | 0.170 |
Why?
| | Precancerous Conditions | 1 | 2002 | 163 | 0.170 |
Why?
| | Receptor, EphB4 | 1 | 2020 | 36 | 0.170 |
Why?
| | Ephrin-B2 | 1 | 2020 | 50 | 0.170 |
Why?
| | Brain | 2 | 2023 | 2679 | 0.160 |
Why?
| | Neoplasms, Experimental | 1 | 2020 | 171 | 0.160 |
Why?
| | Transplantation, Heterologous | 2 | 2016 | 192 | 0.160 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2019 | 94 | 0.160 |
Why?
| | Phthalazines | 1 | 2019 | 41 | 0.160 |
Why?
| | Gonadal Steroid Hormones | 1 | 2020 | 131 | 0.150 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 90 | 0.150 |
Why?
| | Necrosis | 1 | 2019 | 232 | 0.150 |
Why?
| | Tryptophan | 1 | 2018 | 179 | 0.140 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 181 | 0.130 |
Why?
| | Glioblastoma | 1 | 2020 | 326 | 0.130 |
Why?
| | Piperazines | 1 | 2019 | 342 | 0.130 |
Why?
| | Cancer-Associated Fibroblasts | 1 | 2016 | 13 | 0.130 |
Why?
| | Luminescent Measurements | 1 | 2016 | 78 | 0.130 |
Why?
| | ErbB Receptors | 2 | 2020 | 607 | 0.130 |
Why?
| | Prognosis | 2 | 2021 | 3794 | 0.130 |
Why?
| | Antibody Specificity | 1 | 2016 | 184 | 0.130 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1245 | 0.130 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 315 | 0.110 |
Why?
| | STAT5 Transcription Factor | 1 | 2014 | 48 | 0.110 |
Why?
| | Antibodies | 1 | 2016 | 398 | 0.110 |
Why?
| | Phenylthiohydantoin | 1 | 2014 | 44 | 0.110 |
Why?
| | Androgen Receptor Antagonists | 1 | 2014 | 36 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2010 | 769 | 0.110 |
Why?
| | Antigens, Bacterial | 2 | 2005 | 119 | 0.110 |
Why?
| | In Situ Hybridization | 2 | 2010 | 295 | 0.110 |
Why?
| | Rats | 4 | 2020 | 5500 | 0.110 |
Why?
| | Tubulin | 2 | 2012 | 137 | 0.100 |
Why?
| | Up-Regulation | 2 | 2016 | 840 | 0.100 |
Why?
| | Androgen Antagonists | 1 | 2014 | 79 | 0.100 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2015 | 328 | 0.100 |
Why?
| | Signal Transduction | 4 | 2025 | 4925 | 0.100 |
Why?
| | Transfection | 2 | 2012 | 911 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 3 | 2007 | 2406 | 0.100 |
Why?
| | MCF-7 Cells | 3 | 2020 | 116 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 317 | 0.100 |
Why?
| | Tumor Burden | 1 | 2012 | 286 | 0.090 |
Why?
| | Cells, Cultured | 1 | 2019 | 4083 | 0.090 |
Why?
| | Cell Adhesion | 1 | 2012 | 452 | 0.090 |
Why?
| | Blotting, Northern | 1 | 2010 | 200 | 0.090 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 588 | 0.090 |
Why?
| | Receptors, Steroid | 1 | 2010 | 49 | 0.090 |
Why?
| | Cell Size | 1 | 2010 | 89 | 0.090 |
Why?
| | Neoplastic Stem Cells | 1 | 2014 | 380 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2344 | 0.080 |
Why?
| | Ovariectomy | 1 | 2010 | 137 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1706 | 0.080 |
Why?
| | Phosphorylation | 2 | 2020 | 1713 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 958 | 0.080 |
Why?
| | CD146 Antigen | 2 | 2020 | 41 | 0.070 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5440 | 0.070 |
Why?
| | PC12 Cells | 1 | 2007 | 41 | 0.070 |
Why?
| | Subcellular Fractions | 1 | 2007 | 81 | 0.070 |
Why?
| | In Situ Nick-End Labeling | 1 | 2007 | 124 | 0.070 |
Why?
| | Blotting, Western | 2 | 2007 | 1205 | 0.070 |
Why?
| | Gene Products, tat | 1 | 2007 | 21 | 0.070 |
Why?
| | CD11b Antigen | 1 | 2007 | 60 | 0.070 |
Why?
| | Organelles | 1 | 2007 | 54 | 0.070 |
Why?
| | Neuroglia | 1 | 2007 | 168 | 0.060 |
Why?
| | Colombia | 2 | 2005 | 36 | 0.060 |
Why?
| | Helicobacter Infections | 1 | 2005 | 28 | 0.060 |
Why?
| | Adhesins, Bacterial | 1 | 2005 | 40 | 0.060 |
Why?
| | Microglia | 1 | 2007 | 235 | 0.060 |
Why?
| | Disease Progression | 1 | 2012 | 2635 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 769 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 833 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 840 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2007 | 1288 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 232 | 0.050 |
Why?
| | Neoplasm Transplantation | 2 | 2014 | 257 | 0.050 |
Why?
| | Behavior, Animal | 1 | 2007 | 508 | 0.050 |
Why?
| | Gastrointestinal Diseases | 1 | 2005 | 198 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2007 | 570 | 0.050 |
Why?
| | Receptors, Progesterone | 2 | 2016 | 343 | 0.050 |
Why?
| | Aromatase | 1 | 2023 | 31 | 0.050 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2005 | 201 | 0.050 |
Why?
| | Recovery of Function | 1 | 2007 | 642 | 0.050 |
Why?
| | Duodenal Ulcer | 1 | 2002 | 11 | 0.050 |
Why?
| | Gastritis, Atrophic | 1 | 2002 | 6 | 0.050 |
Why?
| | Motor Activity | 1 | 2007 | 676 | 0.050 |
Why?
| | Bacterial Proteins | 2 | 2005 | 835 | 0.050 |
Why?
| | Genetic Markers | 1 | 2002 | 338 | 0.040 |
Why?
| | Chi-Square Distribution | 1 | 2002 | 516 | 0.040 |
Why?
| | Tropism | 1 | 2020 | 1 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2007 | 2548 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2007 | 4063 | 0.040 |
Why?
| | Macrophages | 1 | 2007 | 1480 | 0.040 |
Why?
| | Blood-Brain Barrier | 1 | 2020 | 132 | 0.040 |
Why?
| | Time Factors | 2 | 2007 | 6556 | 0.040 |
Why?
| | Indazoles | 1 | 2019 | 65 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2002 | 1038 | 0.040 |
Why?
| | Tryptophan Oxygenase | 1 | 2018 | 35 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 940 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2020 | 345 | 0.040 |
Why?
| | Male | 6 | 2007 | 63681 | 0.040 |
Why?
| | Kynurenine | 1 | 2018 | 114 | 0.040 |
Why?
| | Piperidines | 1 | 2019 | 199 | 0.040 |
Why?
| | Wnt Signaling Pathway | 1 | 2019 | 170 | 0.030 |
Why?
| | Genetic Variation | 1 | 2002 | 937 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2023 | 10230 | 0.030 |
Why?
| | Genotype | 1 | 2002 | 1839 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 202 | 0.030 |
Why?
| | Indoles | 1 | 2019 | 387 | 0.030 |
Why?
| | Neurons | 1 | 2005 | 1511 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1206 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1877 | 0.030 |
Why?
| | Fibroblasts | 1 | 2020 | 948 | 0.030 |
Why?
| | Middle Aged | 5 | 2019 | 31154 | 0.030 |
Why?
| | Keratin-5 | 1 | 2014 | 50 | 0.030 |
Why?
| | Tosyl Compounds | 1 | 2014 | 16 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 697 | 0.030 |
Why?
| | Anilides | 1 | 2014 | 73 | 0.030 |
Why?
| | Neurotrophin 3 | 1 | 2012 | 9 | 0.030 |
Why?
| | Benzamides | 1 | 2014 | 207 | 0.030 |
Why?
| | Nitriles | 1 | 2014 | 172 | 0.030 |
Why?
| | Autocrine Communication | 1 | 2012 | 43 | 0.030 |
Why?
| | Receptors, Androgen | 1 | 2014 | 147 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2014 | 648 | 0.020 |
Why?
| | Down-Regulation | 1 | 2014 | 636 | 0.020 |
Why?
| | Aged | 3 | 2019 | 22103 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 1952 | 0.020 |
Why?
| | Immunoblotting | 1 | 2010 | 305 | 0.020 |
Why?
| | Adult | 4 | 2019 | 35576 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2010 | 331 | 0.020 |
Why?
| | NF-kappa B | 1 | 2012 | 653 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3083 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3408 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2023 | 14518 | 0.020 |
Why?
| | Gene Expression | 1 | 2010 | 1472 | 0.020 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2005 | 26 | 0.010 |
Why?
| | Genes, Bacterial | 1 | 2005 | 157 | 0.010 |
Why?
| | Cell Count | 1 | 2005 | 314 | 0.010 |
Why?
| | Virulence Factors | 1 | 2005 | 156 | 0.010 |
Why?
| | Cell Death | 1 | 2005 | 354 | 0.010 |
Why?
| | Oligodendroglia | 1 | 2005 | 166 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2005 | 442 | 0.010 |
Why?
| | Interleukin-8 | 1 | 2002 | 262 | 0.010 |
Why?
| | Young Adult | 1 | 2016 | 12426 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2005 | 2708 | 0.010 |
Why?
| | Adolescent | 1 | 2005 | 20393 | 0.000 |
Why?
|
|
Cittelly's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|